308 related articles for article (PubMed ID: 29407877)
1. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: A cross-sectional study in chronic kidney disease patients.
Maeba R; Kojima KI; Nagura M; Komori A; Nishimukai M; Okazaki T; Uchida S
Atherosclerosis; 2018 Mar; 270():102-109. PubMed ID: 29407877
[TBL] [Abstract][Full Text] [Related]
2. Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.
Kanda E; Ai M; Okazaki M; Yoshida M; Maeda Y
PLoS One; 2016; 11(11):e0166459. PubMed ID: 27861640
[TBL] [Abstract][Full Text] [Related]
3. Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells.
Mandel H; Sharf R; Berant M; Wanders RJ; Vreken P; Aviram M
Biochem Biophys Res Commun; 1998 Sep; 250(2):369-73. PubMed ID: 9753636
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional high-density lipoproteins in children with chronic kidney disease.
Kaseda R; Jabs K; Hunley TE; Jones D; Bian A; Allen RM; Vickers KC; Yancey PG; Linton MF; Fazio S; Kon V
Metabolism; 2015 Feb; 64(2):263-73. PubMed ID: 25467845
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
Yamamoto S
Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
[TBL] [Abstract][Full Text] [Related]
6. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
Yamamoto S; Yancey PG; Ikizler TA; Jerome WG; Kaseda R; Cox B; Bian A; Shintani A; Fogo AB; Linton MF; Fazio S; Kon V
J Am Coll Cardiol; 2012 Dec; 60(23):2372-9. PubMed ID: 23141484
[TBL] [Abstract][Full Text] [Related]
7. High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease.
Rysz-Gorzynska M; Gluba-Brzozka A; Banach M
Curr Vasc Pharmacol; 2017; 15(2):144-151. PubMed ID: 27697068
[TBL] [Abstract][Full Text] [Related]
8. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.
Marsche G; Heine GH; Stadler JT; Holzer M
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32967334
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
Kaseda R; Tsuchida Y; Yang HC; Yancey PG; Zhong J; Tao H; Bian A; Fogo AB; Linton MRF; Fazio S; Ikizler TA; Kon V
BMC Nephrol; 2018 Jan; 19(1):17. PubMed ID: 29374468
[TBL] [Abstract][Full Text] [Related]
10. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
[TBL] [Abstract][Full Text] [Related]
11. Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging.
Maeba R; Maeda T; Kinoshita M; Takao K; Takenaka H; Kusano J; Yoshimura N; Takeoka Y; Yasuda D; Okazaki T; Teramoto T
J Atheroscler Thromb; 2007 Feb; 14(1):12-8. PubMed ID: 17332687
[TBL] [Abstract][Full Text] [Related]
12. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients.
Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM
Expert Opin Ther Targets; 2019 Jul; 23(7):619-630. PubMed ID: 31100024
[No Abstract] [Full Text] [Related]
13. High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.
Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shibata T
J Atheroscler Thromb; 2016; 23(1):81-94. PubMed ID: 26289085
[TBL] [Abstract][Full Text] [Related]
14. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
Ogura M; Hori M; Harada-Shiba M
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
[TBL] [Abstract][Full Text] [Related]
15. Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.
Kon V; Yang H; Fazio S
Arch Med Res; 2015 Jul; 46(5):379-91. PubMed ID: 26009251
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol efflux capacity, carotid atherosclerosis, and cerebrovascular symptomatology.
Doonan RJ; Hafiane A; Lai C; Veinot JP; Genest J; Daskalopoulou SS
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):921-6. PubMed ID: 24558111
[TBL] [Abstract][Full Text] [Related]
17. The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan.
Lin TH; Chuang SY; Chu CY; Lee WH; Hsu PC; Su HM; Li YH; Fang CC; Wang KY; Tseng WK; Li AH; Ueng KC; Hsieh IC; Huang LC; Wang CH; Pan WH; Yeh HI; Wu CC; Yin WH; Chen JW
Int J Med Sci; 2014; 11(4):381-8. PubMed ID: 24578616
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.
Ganda A; Yvan-Charvet L; Zhang Y; Lai EJ; Regunathan-Shenk R; Hussain FN; Avasare R; Chakraborty B; Febus AJ; Vernocchi L; Lantigua R; Wang Y; Shi X; Hsieh J; Murphy AJ; Wang N; Bijl N; Gordon KM; de Miguel MH; Singer JR; Hogan J; Cremers S; Magnusson M; Melander O; Gerszten RE; Tall AR
J Mol Cell Cardiol; 2017 Nov; 112():114-122. PubMed ID: 28478047
[TBL] [Abstract][Full Text] [Related]
19. Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome.
Yamazaki Y; Kondo K; Maeba R; Nishimukai M; Nezu T; Hara H
J Oleo Sci; 2014; 63(5):527-37. PubMed ID: 24770479
[TBL] [Abstract][Full Text] [Related]
20. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
Vaziri ND
J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
